Savara (SVRA) Interest Coverage Ratio Growth (5y) (2016 - 2026)
Savara (SVRA) Interest Coverage Ratio Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - |
| 10 | Savara | 1.43 Bn | 1.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.04% |
| Dec 31, 2025 | 384.85% |
| Jun 30, 2025 | -108.55% |
| Mar 31, 2025 | 23.37% |
| Dec 31, 2024 | 0.29% |
| Sep 30, 2024 | -8.34% |
| Jun 30, 2024 | -30.70% |
| Mar 31, 2024 | -33.79% |
| Dec 31, 2023 | 1.79% |
| Sep 30, 2023 | -4.81% |
| Jun 30, 2023 | 22.76% |
| Mar 31, 2023 | 22.95% |
| Dec 31, 2022 | -0.44% |
| Sep 30, 2022 | 2.49% |
| Jun 30, 2022 | 0.64% |
| Mar 31, 2022 | 3.13% |
| Dec 31, 2021 | -5.21% |
| Sep 30, 2021 | -96.86% |
| Jun 30, 2021 | -88.63% |
| Mar 31, 2021 | -45.87% |